| A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma AL Windon, A Loaiza-Bonilla, CE Jensen, M Randall, JJD Morrissette, ... Journal of Gastrointestinal Oncology 9 (1), 1-10, 2017 | 51 | 2017 |
| Cold agglutinin syndrome as a complication of Covid-19 in two cases CE Jensen, S Wilson, A Thombare, S Weiss, A Ma Clinical infection in practice 7, 100041, 2020 | 35 | 2020 |
| KDR mutation as a novel predictive biomarker of exceptional response to regorafenib in metastatic colorectal cancer A Loaiza-Bonilla, CE Jensen, S Shroff, E Furth, PA Bonilla-Reyes, ... Cureus 8 (2), e478, 2016 | 28 | 2016 |
| Differences in overall survival and mutation prevalence between right-and left-sided colorectal adenocarcinoma CE Jensen, JY Villanueva, A Loaiza-Bonilla Journal of Gastrointestinal Oncology 9 (5), 778-784, 2018 | 17 | 2018 |
| Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status CE Jensen, SN Vohra, KA Nyrop, AM Deal, HB Muss, EI Lichtman, ... Journal of geriatric oncology 13 (2), 182-189, 2022 | 14 | 2022 |
| Time spent at home among older adults with acute myeloid leukemia receiving azacitidine-or venetoclax-based regimens CE Jensen, HM Heiling, KE Beke, AM Deal, AL Bryant, LA Coombs, ... Haematologica, 2022 | 12 | 2022 |
| The triage of older adults with physiologic markers of serious injury using a state-wide prehospital plan MH Meyers, TL Wei, JM Cyr, TM Hunold, FS Shofer, CS Cowden, ... Prehospital and disaster medicine 34 (5), 497-505, 2019 | 11 | 2019 |
| Supportive care and symptom management for patients with immunoglobulin light chain (AL) amyloidosis CE Jensen, M Byku, GA Hladik, K Jain, RE Traub, SA Tuchman Frontiers in Oncology 12, 907584, 2022 | 6 | 2022 |
| Physical function, psychosocial status, and symptom burden among adults with plasma cell disorders and associations with quality of life CE Jensen, SN Vohra, KA Nyrop, AM Deal, MR LeBlanc, SJ Grant, ... The Oncologist 27 (8), 694-702, 2022 | 5 | 2022 |
| Time at home among older adults with acute myeloid leukemia based on treatment intensity: A SEER-Medicare analysis. DR Richardson, X Zhou, CE Jensen, KE Reeder-Hayes, JL Lund, ... Journal of Clinical Oncology 40 (16_suppl), 6586-6586, 2022 | 4 | 2022 |
| Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders ZM Nakamura, SN Vohra, CE Jensen, KA Nyrop, AM Deal, HM Heiling, ... Journal of geriatric oncology 13 (7), 987-996, 2022 | 3 | 2022 |
| Immune checkpoint inhibitors for hepatocellular carcinoma CE Jensen, A Loaiza-Bonilla, PA Bonilla-Reyes Hepatic Oncology 3 (3), 201-211, 2016 | 3 | 2016 |
| Physical function, cognitive impairment, and quality-of-life among adults with multiple myeloma and associated plasma cell disorders. CE Jensen, KA Nyrop, S Vohra, AM Deal, HB Muss, EI Lichtman, ... Journal of Clinical Oncology 39 (15_suppl), e20004, 2021 | 2 | 2021 |
| Differences in mutation rates between right-and left-sided colorectal adenocarcinoma. CE Jensen, A Loaiza-Bonilla, JY Villanueva, JJ Morrissette Journal of Clinical Oncology 35 (4_suppl), 622, 2017 | 2 | 2017 |
| Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma CE Jensen, TM Kuo, MR LeBlanc, CD Baggett, ED Duchesneau, X Zhou, ... JCO Clinical Cancer Informatics 8, e2300214, 2024 | 1 | 2024 |
| Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma ARS Yusuf, HM Heiling, AM Deal, CE Jensen, NJ Mangieri, KA Nyrop, ... Clinical Lymphoma Myeloma and Leukemia 22 (12), 920-927, 2022 | 1 | 2022 |
| Time Spent at Home Among Older Adults with AML Treated with Hypomethylating Agents and Venetoclax CE Jensen, HM Heiling, KE Beke, AM Deal, AL Bryant, LA Coombs, ... Blood 138 (Supplement 1), 281-281, 2021 | 1 | 2021 |
| Home time among older adults with acute myeloid leukemia by therapy intensity CE Jensen, AM Deal, AC Wardell, HM Heiling, KE Beke, DR Richardson Haematologica, 2020 | 1 | 2020 |
| Second line therapy in multiple myeloma: A SEER Medicare analysis MR LeBlanc, X Zhou, CD Baggett, S Tuchman, CE Jensen, S Rubinstein Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Fewer severe infections with tranexamic acid in patients with hematologic malignancies JN Poston, SP Brown, A Ilich, AS Ginsburg, H Herren, N El Kassar, ... Research and Practice in Thrombosis and Haemostasis, 102358, 2024 | | 2024 |
Sam RubinsteinUniversity of North Carolina-Chapel HillVerified email at med.unc.edu
